Genetics and Alzheimer's disease;La genetica y la enfermedad de Alzheimer

Revista de Neurologia

Volumn 30, Issue 2, 2000, Pages 161-169

  Perez Tur J ^a  

^a INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

Author keywords

Alzheimer's disease; APOE; A ; Genetics; LRP; PPA; PS1; PS2; Tau

Indexed keywords

AMYLOID PROTEIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; MEMBRANE PROTEIN; PRESENILIN 2; PSEN2 PROTEIN, HUMAN; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; HEALTH CARE COST; HUMAN; MOLECULAR GENETICS; MUTATION; NEUROFILAMENT; AGED; CHROMOSOME 12; GENE EXPRESSION; GENETICS; NUCLEOTIDE SEQUENCE; POINT MUTATION; REVIEW;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEINS E; CHROMOSOMES, HUMAN, PAIR 12; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION; HUMANS; MEMBRANE PROTEINS; POINT MUTATION; PRESENILIN-2; TAU PROTEINS;

EID: 0034673009     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3002.99376     Document Type: Article

References (20)

1. Delacourte A, Sergeant N, Wattez A, Gauvreau D, Robitaille Y. Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation. Ann Neurol 1998; 43: 193-204.
2. Mailliot C, Sergeant N, Bussiere T, Cailliet-Boudin ML, Delacourte A, Buee L. Phosphorylation of specific sets of tau isoforms explains different neurodegeneration processes. FEBS Letters 1998; 433: 201-4.
3. Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 1991; 12: 383-8.
4. Roses A. Alzheimer diseases: a model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases. Am J Med Genet 1998; 81: 49-57.
5. St George-Hyslop P, Tanzi RE, Polinsky RJ, Haines JL, Nee L, Watkins PC, et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 1987; 235: 885-90.
6. Tanzi RE, Gusella JF, Watkins PC, Brun, GAP, St George-Hyslop P, Van Keuren ML, et al. Amyloid β-protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 1987; 235: 880-4.
7. Tanzi RE, St George-Hyslop PH, Haines JL, Polinsky RJ, Nee L, Foncin JF, et al. The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid β-protein gene. Nature 1987; 329: 156-7.
8. Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 1991; 353: 844-6.
9. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-6.
10. Selkoe DJ. Amyfold beta-protein and the genetics of Alzheimer's disease. J Biol Chem 1996; 271: 18295-8.
11. Mullan M, Houlden H, Windelspecht M, Fidani L, Lombardi C, Diaz P, et al. A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene. Nat Genet 1992; 2: 340-2.
12. Schellenberg CD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens E, et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992; 258: 668-71.
13. St George-Hyslop P, Haines J, Rogaev E, Mortilla M, Vaula G, Pericak-Vance M, et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet 1992; 2: 330-4.
14. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754-60.
15. Cruts M, Van Broeckhoven C. Presenilin mutations in Alzheimcr's disease. Human Mutation 1998; 11: 183-90.
16. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 1997; 89: 629-39.
17. Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, Kim G, et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 1996; 17: 181-90.
18. Tysoe C, Whittaker J, Xuereb J, Cairns NJ, Cruts M, Van Broeckhoven C, et al. A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease. Am J Hum Genet 1998; 62: 70-6.
19. Crook R, Verkkoniemi A, Pérez-Tur J, Mehta N, Baker M, Houlden H, et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin I. Nature Med 1998; 4: 452-5.
20. Ishii K, li K, Hasegawa T, Shoji S, Doi A, Mori H. Increased A beta 42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of cxon 9 and the missense point mutation (H163R) in the PS-1 gene. Neurosci Lett 1997; 228: 17-20.